Source:http://linkedlifedata.com/resource/pubmed/id/17661444
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
33
|
pubmed:dateCreated |
2007-8-16
|
pubmed:abstractText |
High-molecular weight thioredoxin reductases (TRs) catalyze the reduction of the redox-active disulfide bond of thioredoxin, but an important difference in the TR family is the sequence of the C-terminal redox-active tetrapeptide that interacts directly with thioredoxin, especially the presence or absence of a selenocysteine (Sec) residue in this tetrapeptide. In this study, we have employed protein engineering techniques to investigate the C-terminal redox-active tetrapeptides of three different TRs: mouse mitochondrial TR (mTR3), Drosophila melanogaster TR (DmTR), and the mitochondrial TR from Caenorhabditis elegans (CeTR2), which have C-terminal tetrapeptide sequences of Gly-Cys-Sec-Gly, Ser-Cys-Cys-Ser, and Gly-Cys-Cys-Gly, respectively. Three different types of mutations and chemical modifications were performed in this study: insertion of alanine residues between the cysteine residues of the Cys-Cys or Cys-Sec dyads, modification of the charge at the C-terminus, and altering the position of the Sec residue in the mammalian enzyme. The results show that mTR3 is quite accommodating to insertion of alanine residues into the Cys-Sec dyad, with only a 4-6-fold drop in catalytic activity. In contrast, the activity of both DmTR and CeTR2 was reduced 100-300-fold when alanine residues were inserted into the Cys-Cys dyad. We have tested the importance of a salt bridge between the C-terminus and a basic residue that was proposed for orienting the Cys-Sec dyad of mTR3 for proper catalytic position by changing the C-terminal carboxylate to a carboxamide. The result is an enzyme with twice the activity as the wild-type mammalian enzyme. A similar result was achieved when the C-terminal carboxylate of DmTR was converted to a hydroxamic acid or a thiocarboxylate. Last, reversing the positions of the Cys and Sec residues in the catalytic dyad resulted in a 100-fold loss of catalytic activity. Taken together, the results support our previous model of Sec as the leaving group during reduction of the C-terminus during the catalytic cycle.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9472-83
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17661444-Amino Acid Sequence,
pubmed-meshheading:17661444-Animals,
pubmed-meshheading:17661444-Caenorhabditis elegans,
pubmed-meshheading:17661444-Dinitrobenzenes,
pubmed-meshheading:17661444-Drosophila melanogaster,
pubmed-meshheading:17661444-Electron Transport,
pubmed-meshheading:17661444-Escherichia coli,
pubmed-meshheading:17661444-Hydrogen-Ion Concentration,
pubmed-meshheading:17661444-Mice,
pubmed-meshheading:17661444-Molecular Weight,
pubmed-meshheading:17661444-Mutation,
pubmed-meshheading:17661444-Oxidation-Reduction,
pubmed-meshheading:17661444-Peroxidase,
pubmed-meshheading:17661444-Protein Engineering,
pubmed-meshheading:17661444-Thioredoxin-Disulfide Reductase
|
pubmed:year |
2007
|
pubmed:articleTitle |
Investigation of the C-terminal redox center of high-Mr thioredoxin reductase by protein engineering and semisynthesis.
|
pubmed:affiliation |
Department of Biochemistry, University of Vermont, 89 Beaumont Avenue, Given Laboratory, Room B413, Burlington, Vermont 05405, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|